http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110064077-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-047
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04
filingDate 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110064077-B
titleOfInvention Silk fibroin hydrogel for uterine cavity adhesion treatment
abstract The invention provides silk fibroin hydrogel for uterine cavity adhesion treatment, which mainly comprises silk fibroin, poloxamer, cyclic dipeptide, liquid fluorocarbon and green indole phthalocyanine, wherein the green indole phthalocyanine has a photothermal effect, and the liquid fluorocarbon can be quickly converted into gas under the action of heat energy. Therefore, after the silk fibroin hydrogel for uterine cavity adhesion treatment is administered by applying an in-situ injection mode in the uterine cavity, the silk fibroin hydrogel can be rapidly expanded to form elastic three-dimensional hydrogel full of pores by irradiating in the uterine cavity by applying 785nm near infrared light, and the silk fibroin hydrogel is used for the efficient treatment of the uterine cavity adhesion.
priorityDate 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017058672-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411556313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86280045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66718645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448768301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411168116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450270349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66601411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452228728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426132900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18602339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7074739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87089927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448836125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756

Total number of triples: 47.